Abstract
We have recently reported that lowering the pH to values that are frequently detected in tumors causes reversible anergy in both human and mouse CD8+ T lymphocytes in vitro. The same occurs in vivo, in the tumor microenvironment and the administration of proton pump inhibitors, which buffer tumor acidity, can revert T-cell anergy and increase the efficacy of immunotherapy.
Original language | English |
---|---|
Article number | e22058 |
Journal | OncoImmunology |
Volume | 2 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 2013 |
Keywords
- Active immunotherapy
- Adoptive immunotherapy
- Anergy
- Melanoma
- Prostate cancer
- T cell
ASJC Scopus subject areas
- Immunology and Allergy
- Oncology
- Immunology